8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications

References

• Short BR Vargas MA Thomas JC O’Hanlon S Enright MC In vitro activity of a novel compound, the metal ion chelating agent AQ+, against clinical isolates of Staphylococcus aureus J Antimicrob Chemother 2006 57 1 104 109 16319182
   PubMed Web of Science ®Google Scholar
• Albrecht M Fiege M Osetska O 8-Hydroxyquinolines in metallosupramolecular chemistry Coord Chem Rev 2008 252 8–9 812 824
   Web of Science ®Google Scholar
• Budimir A Metal ions, Alzheimer’s disease and chelation therapy Acta Pharm 2011 61 1 1 14 21406339
   PubMed Web of Science ®Google Scholar
• Crichton RR Dexter DT Ward RJ Metal based neurodegenerative diseases-From molecular mechanisms to therapeutic strategies Coord Chem Rev 2008 252 10–11 1189 1199
   Web of Science ®Google Scholar
• Vanparia SF Patel TS Sojitra NA Synthesis, characterization and antimicrobial study of novel 4-{[(8-Hydroxyquinolin-5-yl) methyl]amino}benzenesulfonamide and its oxinates Acta Chim Slov 2010 57 3 600 667
   Web of Science ®Google Scholar
• Rubbo SD Albert A Gibson MI The influence of chemical constitution on antibacterial activity. V. The antibacterial action of 8-hydroxyquinoline (oxine) Br J Exp Pathol 1950 31 3 425 441 14772392
   PubMedGoogle Scholar
• Crichton RR Dexter DT Ward RJ Brain iron metabolism and its perturbation in neurological diseases J Neural Transm 2011 118 3 301 314 20809066
   PubMed Web of Science ®Google Scholar
• Tõugu V Palumaa P Coordination of zinc ions to the key proteins of neurodegenerative diseases: Aβ, APP, α-synuclein and PrP Coord Chem Rev 2012 256 19–20 2219 2224
   Web of Science ®Google Scholar
• Bush AI The metallobiology of Alzheimer’s disease Trends Neurosci 2003 26 4 207 214 12689772
   PubMed Web of Science ®Google Scholar
• Bush AI Tanzi RE Therapeutics for Alzheimer’s disease based on the metal hypothesis Neurotherapeutics 2008 5 3 421 432 18625454
   PubMed Web of Science ®Google Scholar
• Gaeta A Hider RC The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy Br J Pharmacol 2005 146 8 1041 1059 16205720
   PubMed Web of Science ®Google Scholar
• Zatta P Drago D Bolognin S Sensi SL Alzheimer’s disease, metal ions and metal homeostatic therapy Trends Pharmacol Sci 2009 30 7 346 355 19540003
   PubMed Web of Science ®Google Scholar
• Perez LR Franz KJ Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease Dalton Trans 2010 39 9 2177 2187 20162187
   PubMed Web of Science ®Google Scholar
• Crouch PJ Barnham KJ Therapeutic redistribution of metal ions to treat Alzheimer’s disease Acc Chem Res 2012 45 9 1604 1611 22747493
   PubMed Web of Science ®Google Scholar
• Zheng H Gal S Weiner LM Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition J Neurochem 2005 95 1 68 78 16181413
   PubMed Web of Science ®Google Scholar
• Kaur D Yantiri F Rajagopalan S Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson’s disease Neuron 2003 37 6 899 909 12670420
   PubMed Web of Science ®Google Scholar
• Zheng H Youdim MB Weiner LM Fridkin M Synthesis and evaluation of peptidic metal chelators for neuroprotection in neurodegenerative diseases J Pept Res 2005 66 4 190 203 16138857
   PubMedGoogle Scholar
• Deraeve C Pitié M Mazarguil H Meunier B Bis-8-hydroxyquinoline ligands as potential anti-Alzheimer agents New J Chem 2007 31 2 193 195
   Web of Science ®Google Scholar
• Ritchie CW Bush AI Mackinnon A Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial Arch Neurol 2003 60 12 1685 1691 14676042
   PubMed Web of Science ®Google Scholar
• Cherny RA Atwood CS Xilinas ME Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer’s disease transgenic mice Neuron 2001 30 3 665 676 11430801
   PubMed Web of Science ®Google Scholar
• Tateishi J Subacute myelo-optico-neuropathy: clioquinol intoxication in humans and animals Neuropathology 2000 20 Suppl S20 S24 11037182
   PubMed Web of Science ®Google Scholar
• Yassin MS Ekblom J Xilinas M Gottfries CG Oreland L Changes in uptake of vitamin B(12) and trace metals in brains of mice treated with clioquinol J Neurol Sci 2000 173 1 40 44 10675578
   PubMed Web of Science ®Google Scholar
• Budimir A Humbert N Elhabiri M Osinska I Biruš M Albrecht-Gary AM Hydroxyquinoline based binders: promising ligands for chelatotherapy? J Inorg Biochem 2011 105 3 490 496 20926137
   PubMed Web of Science ®Google Scholar
• LeVine H Ding Q Walker JA Voss RS Augelli-Szafran CE Clioquinol and other hydroxyquinoline derivatives inhibit Abeta (1-42) oligomer assembly Neurosci Lett 2009 465 1 99 103 19664688
   PubMed Web of Science ®Google Scholar
• White AR Du T Laughton KM Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity J Biol Chem 2006 281 26 17670 17680 16648635
   PubMed Web of Science ®Google Scholar
• Adlard PA Cherny RA Finkelstein DI Rapid restoration of cognition in Alzheimer’s transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta Neuron 2008 59 1 43 55 18614028
   PubMed Web of Science ®Google Scholar
• Crouch PJ Savva MS Hung LW The Alzheimer’s therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity J Neurochem 2011 119 1 220 230 21797865
   PubMed Web of Science ®Google Scholar
• Adlard PA Bica L White AR Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer’s disease PLoS One 2011 6 3 e17669 21412423
   PubMed Web of Science ®Google Scholar
• Lannfelt L Blennow K Zetterberg H PBT2-201-EURO study group Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer’s disease: a phase IIa, double-blind, randomised, placebo-controlled trial Lancet Neurol 2008 7 9 779 786 18672400
   PubMed Web of Science ®Google Scholar
• Faux NG Ritchie CW Gunn A PBT2 rapidly Improves cognition in Alzheimer’s disease: additional Phase II analyses J Alzheimers Dis 2010 20 2 509 516 20164561
   PubMed Web of Science ®Google Scholar
• Crouch PJ Tew DJ Du T Restored degradation of the Alzheimer’s amyloid-beta peptide by targeting amyloid formation J Neurochem 2009 108 5 1198 1207 19141082
   PubMed Web of Science ®Google Scholar
• Gal S Fridkin M Amit T Zheng H Youdim MBH M30, a novel multifunctional neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-ab inhibitory activity for Parkinson’s disease J Neural Transm Suppl 2006 70 447 456 17017567
   PubMedGoogle Scholar
• Kasarskis EJ Tandon L Lovell MA Ehmann WD Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study J Neurol Sci 1995 130 2 203 208 8586987
   PubMed Web of Science ®Google Scholar
• Pollak Y Mechlovich D Amit T Effects of novel neuroprotective and neurorestorative multifunctional drugs on iron chelation and glucose metabolism J Neural Transm 2013 120 1 37 48 22446839
   PubMed Web of Science ®Google Scholar
• Riederer P Sofic E Rausch WD Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains J Neurochem 1989 52 2 515 520 2911028
   PubMed Web of Science ®Google Scholar
• Paris I Martinez-Alvarado P Cárdenas S Dopamine-dependent iron toxicity in cells derived from rat hypothalamus Chem Res Toxicol 2005 18 3 415 419 15777081
   PubMed Web of Science ®Google Scholar
• Zheng H Weiner LM Bar-Am O Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer’s, Parkinson’s, and other neurodegenerative diseases Bioorg Med Chem 2005 13 3 773 783 15653345
   PubMed Web of Science ®Google Scholar
• Avramovich-Tirosh Y Amit T Bar-Am O Zheng H Fridkin M Youdim MB Therapeutic targets and potential of the novel brain-permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer’s disease J Neurochem 2007 100 2 490 502 17144902
   PubMed Web of Science ®Google Scholar
• Avramovich-Tirosh Y Bar-Am O Amit T Youdim MB Weinreb O Up-regulation of hypoxia-inducible factor (HIF)-1α and HIF-target genes in cortical neurons by the novel multifunctional iron chelator anti-Alzheimer drug, M30 Curr Alzheimer Res 2010 7 4 300 306 20043814
   PubMed Web of Science ®Google Scholar
• Kupershmidt L Weinreb O Amit T Mandel S Carri MT Youdim MB Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis FASEB J 2009 23 11 3766 3779 19638399
   PubMed Web of Science ®Google Scholar
• Weinreb O Mandel S Bar-Am O Amit T Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer’s disease: a tribute to Moussa Youdim J Neural Transm 2011 118 3 479 492 21360301
   PubMed Web of Science ®Google Scholar
• Youdim MB Weinstock M Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation Neurotoxicology 2004 25 1–2 243 250 14697899
   PubMed Web of Science ®Google Scholar
• Stevens RG Kalkwarf DR Iron, radiation, and cancer Environ Health Perspect 1990 87 291 300 2269234
   PubMed Web of Science ®Google Scholar
• Brem S Angiogenesis and cancer control: from concept to therapeutic trial Cancer Control 1999 6 5 436 458 10758576
   PubMedGoogle Scholar
• Brewer GJ Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson’s disease Exp Biol Med (Maywood) 2001 226 7 665 673 11444102
   PubMed Web of Science ®Google Scholar
• Theophanides T Anastassopoulou J Copper and carcinogenesis Crit Rev Oncol Hematol 2002 42 1 57 64 11923068
   PubMed Web of Science ®Google Scholar
• Daniel KG Harbach RH Guida WC Dou QP Copper storage diseases: Menkes, Wilsons, and cancer Front Biosci 2004 9 2652 2662 15358588
   PubMed Web of Science ®Google Scholar
• Gupte A Mumper RJ Elevated copper and oxidative stress in cancer cells as a target for cancer treatment Cancer Treat Rev 2009 35 1 32 46 18774652
   PubMed Web of Science ®Google Scholar
• Andrews NC Disorders of iron metabolism N Engl J Med 1999 341 26 1986 1995 10607817
   PubMed Web of Science ®Google Scholar
• Le NT Richardson DR The role of iron in cell cycle progression and the proliferation of neoplastic cells Biochim Biophys Acta 2002 1603 1 31 46 12242109
   PubMed Web of Science ®Google Scholar
• Halliwell B Gutteridge JM Cross CE Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med 1992 119 6 598 620 1593209
   PubMed Web of Science ®Google Scholar
• Cerutti PA Oxy-radicals and cancer Lancet 1994 344 8926 862 863 7916406
   PubMed Web of Science ®Google Scholar
• Leanderson P Tagesson C Rapid and sensitive detection of hydroxyl radicals formed by activated neutrophils in the presence of chelated iron: hydroxylation of deoxyguanosine to 8-hydroxydeoxyguanosine Agents Actions 1992 36 1–2 50 57 1414689
   PubMedGoogle Scholar
• Leanderson P Tagesson C Iron bound to the lipophilic iron chelator, 8-hydroxyquinoline, causes DNA strand breakage in cultured lung cells Carcinogenesis 1996 17 3 545 550 8631142
   PubMed Web of Science ®Google Scholar
• Jonas SK Riley PA The effect of ligands on the uptake of iron by cells in culture Cell Biochem Funct 1991 9 4 245 253 1725507
   PubMed Web of Science ®Google Scholar
• Schraufstatter IU Hinshaw DB Hyslop PA Spragg RG Cochrane CG Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide J Clin Invest 1986 77 4 1312 1320 2937805
   PubMed Web of Science ®Google Scholar
• Zhou ZH Ando S Furutsuka D Ikebe M Characterization of Ca2+/calmodulin-dependent protein kinase II from smooth muscle Biochem J 1995 310 Pt 2 517 525 7654190
   PubMed Web of Science ®Google Scholar
• Hecht SM DNA strand scission by activated bleomycin group antibiotics Fed Proc 1986 45 12 2784 2791 2429877
   PubMedGoogle Scholar
• Shaw AY Chang CY Hsu MY Synthesis and structure-activity relationship study of 8-hydroxyquinoline-derived Mannich bases as anticancer agents Eur J Med Chem 2010 45 7 2860 2867 20359788
   PubMed Web of Science ®Google Scholar
• Lescoat G Léonce S Pierré A Gouffier L Gaboriau F Antiproliferative and iron chelating efficiency of the new bis-8-hydroxyquinoline benzylamine chelator S1 in hepatocyte cultures Chem Biol Interact 2012 195 2 165 172 22197641
   PubMed Web of Science ®Google Scholar
• Moor EC In methods in enzymology Colowick SP Kaplan ND Method in Enzymology New York, NY Academic 1967 12 Pt A 155
   Google Scholar
• Yamato M Hashigaki K Yasumoto Y Synthesis and antitumor activity of tropolone derivatives. 6. Structure-activity relationships of antitumor-active tropolone and 8-hydroxyquinoline derivatives J Med Chem 1987 30 10 1897 1900 3116257
   PubMed Web of Science ®Google Scholar
• Prachayasittikul S Worachartcheewan A Pingaew R Metal complexes of uracil derivatives with cytotoxicity and superoxide scavenging activity Lett Drug Des Dis 2012 9 3 282 287
   Web of Science ®Google Scholar
• Boerner LJ Zaleski JM Metal complex-DNA interactions: from transcription inhibition to photoactivated cleavage Curr Opin Chem Biol 2005 9 2 135 144 15811797
   PubMed Web of Science ®Google Scholar
• Colak A Terzi Ü Col M DNA binding, antioxidant and antimicrobial activities of homo- and heteronuclear copper(II) and nickel(II) complexes with new oxime-type ligands Eur J Med Chem 2010 45 11 5169 5175 20817331
   PubMed Web of Science ®Google Scholar
• Mathur S Tabassum S New homodi-and heterotrinuclear metal complexes of Schiff base compartmental ligand: Interaction studies of copper complexes with calf thymus DNA Cent Eur J Chem 2006 4 3 502 522
   Google Scholar
• Cowan JA Chemical nucleases Curr Opin Chem Biol 2001 5 6 634 642 11738172
   PubMed Web of Science ®Google Scholar
• Tan J Wang B Zhu L DNA binding, cytotoxicity, apoptotic inducing activity, and molecular modeling study of quercetin zinc(II) complex Bioorg Med Chem 2009 17 2 614 620 19097913
   PubMed Web of Science ®Google Scholar
• Dixit RB Patel TS Vanparia SF Kunjadiya AP Keharia HR Dixit BC DNA-binding interaction studies of microwave assisted synthesized sulfonamide substituted 8-hydroxyquinoline derivatives Sci Pharm 2011 79 2 293 308 21773067
   PubMedGoogle Scholar
• Xu H Zheng KC Chen Y Effects of ligand planarity on the interaction of polypyridyl Ru(II) complexes with DNA Dalton Trans 2003 11 2260 2268
   Web of Science ®Google Scholar
• Delaney S Pascaly M Bhattacharya PK Han K Barton JK Oxidative damage by ruthenium complexes containing the dipyridophenazine ligand or its derivatives: a focus on intercalation Inorg Chem 2002 41 7 1966 1974 11925195
   PubMed Web of Science ®Google Scholar
• Siddiqi ZA Khalid M Kumar S Shahid M Noor S Antimicrobial and SOD activities of novel transition metal complexes of pyridine-2,6-dicarboxylic acid containing 4-picoline as auxiliary ligand Eur J Med Chem 2010 45 1 264 269 19897283
   PubMed Web of Science ®Google Scholar
• Serbest K Colak A Güner S Karaböcek S Kormali F Copper(II)– manganese(II) complexes of 3,3′-(1,3-propanediyldiimine)bis-(3-methyl-2-butanone)dioxime with superoxide dismutase-like activity Transit Metal Chem 2001 26 6 625 629
   Web of Science ®Google Scholar
• Saheki T Ueda A Hosoya M Qualitative and quantitative abnormalities of argininosuccinate synthetase in citrullinemia Clin Chim Acta 1981 109 3 325 335 6784969
   PubMed Web of Science ®Google Scholar
• Nayak SB Bhat VR Upadhyay D Udupa SL Copper and ceruloplasmin status in serum of prostate and colon cancer patients Indian J Physiol Pharmacol 2003 47 1 108 110 12708132
   PubMedGoogle Scholar
• Huang YL Sheu JY Lin TH Association between oxidative stress and changes of trace elements in patients with breast cancer Clin Biochem 1999 32 2 131 136 10211630
   PubMed Web of Science ®Google Scholar
• Rizk SL Sky-Peck HH Comparison between concentrations of trace elements in normal and neoplastic human breast tissue Cancer Res 1984 44 11 5390 5394 6488192
   PubMed Web of Science ®Google Scholar
• Turecký L Kalina P Uhliková E Námerová S Krizko J Serum ceruloplasmin and copper levels in patients with primary brain tumors Klin Wochenschr 1984 62 4 187 189 6323815
   PubMedGoogle Scholar
• Chen D Cui QC Yang H Clioquinol, a therapeutic agent for Alzheimer’s disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts Cancer Res 2007 67 4 1636 1644 17308104
   PubMed Web of Science ®Google Scholar
• Ding WQ Lind SE Metal ionophores – an emerging class of anticancer drugs IUBMB Life 2009 61 11 1013 1018 19859983
   PubMed Web of Science ®Google Scholar
• Daniel KG Chen D Orlu S Cui QC Miller FR Dou QP Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells Breast Cancer Res 2005 7 6 R897 R908 16280039
   PubMed Web of Science ®Google Scholar
• Mao X Li X Sprangers R Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma Leukemia 2009 23 3 585 590 18754030
   PubMed Web of Science ®Google Scholar
• Lind SE Park JS Drexler JW Pyrithione and 8-hydroxyquinolines transport lead across erythrocyte membranes Transl Res 2009 154 3 153 159 19665691
   PubMed Web of Science ®Google Scholar
• Ding WQ Liu B Vaught JL Yamauchi H Lind SE Anticancer activity of the antibiotic clioquinol Cancer Res 2005 65 8 3389 3395 15833873
   PubMed Web of Science ®Google Scholar
• Yu H Zhou Y Lind SE Ding WQ Clioquinol targets zinc to lysosomes in human cancer cells Biochem J 2009 417 1 133 139 18764784
   PubMed Web of Science ®Google Scholar
• Andersson DA Gentry C Moss S Bevan S Clioquinol and pyrithione activate TRPA1 by increasing intracellular Zn2+ Proc Natl Acad Sci U S A 2009 106 20 8374 8379 19416844
   PubMed Web of Science ®Google Scholar
• Ruschak AM Slassi M Kay LE Schimmer AD Novel proteasome inhibitors to overcome bortezomib resistance J Natl Cancer Inst 2011 103 13 1007 1017 21606441
   PubMedGoogle Scholar
• Geraki K Farquharson MJ Bradley DA Concentrations of Fe, Cu and Zn in breast tissue: a synchrotron XRF study Phys Med Biol 2002 47 13 2327 2339 12164590
   PubMed Web of Science ®Google Scholar
• Dìez M Cerdàn FJ Arroyo M Balibrea JL Use of the copper/zinc ratio in the diagnosis of lung cancer Cancer 1989 63 4 726 730 2914279
   PubMed Web of Science ®Google Scholar
• Yoshida D Ikeda Y Nakazawa S Quantitative analysis of copper, zinc and copper/zinc ratio in selected human brain tumors J Neurooncol 1993 16 2 109 115 8289088
   PubMed Web of Science ®Google Scholar
• Daniel KG Gupta P Harbach RH Guida WC Dou QP Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells Biochem Pharmacol 2004 67 6 1139 1151 15006550
   PubMed Web of Science ®Google Scholar
• Dorkin TJ Neal DE Basic science aspects of prostate cancer Semin Cancer Biol 1997 8 1 21 27 9299578
   PubMed Web of Science ®Google Scholar
• Arnold JT Isaacs JT Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell’s fault Endocr Relat Cancer 2002 9 1 61 73 11914183
   PubMed Web of Science ®Google Scholar
• Yu H Lou JR Ding WQ Clioquinol independently targets NF-kappaB and lysosome pathways in human cancer cells Anticancer Res 2010 30 6 2087 2092 20651355
   PubMed Web of Science ®Google Scholar
• Ding WQ Yu HJ Lind SE Zinc-binding compounds induce cancer cell death via distinct modes of action Cancer Lett 2008 271 2 251 259 18639975
   PubMed Web of Science ®Google Scholar
• Jiang H Taggart JE Zhang X Benbrook DM Lind SE Ding WQ Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline) Cancer Lett 2011 312 1 11 17 21899946
   PubMed Web of Science ®Google Scholar
• Arbiser JL Kraeft SK van Leeuwen R Clioquinol-zinc chelate: a candidate causative agent of subacute myelo-optic neuropathy Mol Med 1998 4 10 665 670 9848083
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics Committee on Drugs: Clioquinol (iodochlorhydroxyquin, vioform) and iodoquinol (diiodohydroxyquin): blindness and neuropathy Pediatrics 1990 86 5 797 798 2146587
   PubMed Web of Science ®Google Scholar
• Oliveri V Giuffrida ML Vecchio G Aiello C Viale M Gluconjugates of 8-hydroxyquinolines as potential anti-cancer prodrugs Dalton Trans 2012 41 15 4530 4535 22354329
   PubMed Web of Science ®Google Scholar
• Kawamura T Kusakabe T Sugino T Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival Cancer 2001 92 3 634 641 11505409
   PubMed Web of Science ®Google Scholar
• Arafa HM Possible contribution of beta-glycosidases and caspases in the cytotoxicity of novel glycoconjugates in colon cancer cells Invest New Drugs 2010 28 3 306 317 19415182
   PubMed Web of Science ®Google Scholar
• Pavlov A Takuchev N Georgieva N Drug design by regression analyses of newly synthesized derivatives of 8-quinolinol Biotechnol Biotechnol Equip 2011 26 1 164 169
   Google Scholar
• Jeon JH Lee CH Lee HS Antimicrobial activities of 2-methyl-8-hydroxyquinoline and its derivatives against human intestinal bacteria J Korean Soc Appl Biol Chem 2009 52 2 202 205
   Google Scholar
• Ahmed SM Ismail DA Synthesis and biological activity of 8-hydroxyquinoline and 2-hydroxypyridine quaternary ammonium salts J Surfact Deterg 2008 11 3 231 235
   Web of Science ®Google Scholar
• Strobl JS Seibert CW Li Y Inhibition of Toxoplasma gondii and Plasmodium falciparum infections in vitro by NSC3852, a redox active antiproliferative and tumor cell differentiation agent J Parasitol 2009 95 1 215 223 18837587
   PubMed Web of Science ®Google Scholar
• Scheibel LW Adler A Antimalarial activity of selected aromatic chelators. III. 8-Hydroxyquinolines (oxines) substituted in positions 5 and 7, and oxines annelated in position 5,6 by an aromatic ring Mol Pharmacol 1982 22 1 140 144 6811856
   PubMed Web of Science ®Google Scholar
• Madrid PB Sherrill J Liou AP Weisman JL Derisi JL Guy RK Synthesis of ring-substituted 4-aminoquinolines and evaluation of their antimalarial activities Bioorg Med Chem Lett 2005 15 4 1015 1018 15686903
   PubMed Web of Science ®Google Scholar
• Moret V Dereudre-Bosquet N Clayette P Synthesis and anti-HIV properties of new hydroxyquinoline-polyamine conjugates on cells infected by HIV-1 LAV and HIV-1 BaL viral strains Bioorg Med Chem Lett 2006 16 23 5988 5992 17000109
   PubMed Web of Science ®Google Scholar
• Darby CM Nathan CF Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline J Antimicrob Chemother 2010 65 7 1424 1427 20435781
   PubMed Web of Science ®Google Scholar
• Warner VD Musto JD Sane JN Kim KH Grunewald GL Quantitative structure-activity relationships for 5-substituted 8-hydroxyquinolines as inhibitors of dental plaque J Med Chem 1977 20 1 92 96 401891
   PubMed Web of Science ®Google Scholar
• Tanzer JM Slee AM Kamay B Scheer E Activity of three 8-hydroxyquinoline derivatives against in vitro dental plaque Antimicrob Agents Chemother 1978 13 6 1044 1045 98105
   PubMed Web of Science ®Google Scholar
• Ananthan S Faaleolea ER Goldman RC High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv Tuberculosis (Edinb) 2009 89 5 334 353 19758845
   PubMed Web of Science ®Google Scholar
• Kharadi GJ Patel JR Dholakiya BZ Antituberculosis, antifungal and thermal activity of mixed ligand transition metal complexes Appl Organomet Chem 2010 24 11 821 827
   Web of Science ®Google Scholar
• Irish D Eltringham I Teall A Control of an outbreak of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin J Hosp Infect 1998 39 1 19 26 9617681
   PubMed Web of Science ®Google Scholar
• Takahashi N Microbial ecosystem in the oral cavity: metabolic diversity in an ecological niche and its relationship with oral diseases Proceedings of the International Symposium for Interface Oral Health, Sendai, Japan, 2–3 February 2005 International Congress Series 2005 1284 103 112
   Google Scholar
• Rathsam C Eaton RE Simpson CL Two-dimensional fluorescence difference gel electrophoretic analysis of Streptococcus mutans biofilms J Proteome Res 2005 4 6 2161 2173 16335963
   PubMed Web of Science ®Google Scholar
• Lemos JA Abranches J Burne RA Responses of cariogenic streptococci to environmental stresses Curr Issues Mol Biol 2005 7 1 95 107 15580782
   PubMed Web of Science ®Google Scholar
• Albert A Magrath D The choice of a chelating agent for inactivating trace metals: II. Derivatives of oxine (8-hydroxyquinoline) Biochem. J 1947 41 4 534 530
   Web of Science ®Google Scholar
• Albert A Gibson MI Rubbo SD The influence of chemical constitution on antibacterial activity. VI. The bactericidal action of 8-hydroxyquinoline (oxine) Br J Exp Pathol 1953 34 2 119 130 13051519
   PubMedGoogle Scholar
• Anjaneyulu Y Rao RP Swamy RY Eknath A Rao KN In vitro antimicrobial-activity studies on the mixed ligand complexes of Hg(II) with 8-hydroxyquinoline and salicylic acids Proc Indian Acad Sci (Chem Sci) 1982 91 2 157 163
   Google Scholar
• Srisung S Suksrichavalit T Prachayasittikul S Ruchirawat S Prachayasittikul V Antimicrobial activity of 8-hydroxyquinoline and transition metal complexes Int J Pharmacol 2013 9 2 170 175
   Web of Science ®Google Scholar
• Shen AY Chen CP Roffler S A chelating agent possessing cytotoxicity and antimicrobial activity: 7-morpholinomethyl-8-hydroxyquinoline Life Sci 1999 64 9 813 825 10075114
   PubMed Web of Science ®Google Scholar
• Badawi AM Mohamed MA Mohamed MZ Khowdairy MM Surface and antitumor activity of some novel metal-based cationic surfactants J Cancer Res Ther 2007 3 4 198 206 18270394
   PubMedGoogle Scholar
• Rohde W Mikelens P Jackson J Blackman J Whitcher J Levinson W Hydroxyquinolines inhibit ribonucleic acid-dependent deoxyribonucleic acid polymerase and inactivate Rous sarcoma virus and herpes simplex virus Antimicrob Agents Chemother 1976 10 2 234 240 185949
   PubMed Web of Science ®Google Scholar
• Auld DS Kawaguchi H Livingston DM Vallee BL RNA-dependent DNA polymerase (reverse transcriptase) from avian myeloblastosis virus: a zinc metalloenzyme Proc Natl Acad Sci U S A 1974 71 5 2091 2095 4134617
   PubMed Web of Science ®Google Scholar
• Valenzuela P Morris RW Faras A Levinson W Rutter WJ Are all nucleotidyl transferases metalloenzymes? Biochem Biophys Res Commun 1973 53 3 1036 1041 4125981
   PubMed Web of Science ®Google Scholar
• Albert A Quantitative studies of the avidity of naturally occurring substances for trace metals. III. Pteridines, riboflavin and purines Biochem J 1953 54 4 646 654 13058968
   PubMed Web of Science ®Google Scholar
• De Clercq E Antiviral drug discovery and development: where chemistry meets with biomedicine Antiviral Res 2005 67 2 56 75 16046240
   PubMed Web of Science ®Google Scholar
• De Clercq E HIV-chemotherapy and -prophylaxis: new drugs, leads and approaches Int J Biochem Cell Biol 2004 36 9 1800 1822 15183346
   PubMed Web of Science ®Google Scholar
• Hatse S Princen K Gerlach LO Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100 Mol Pharmacol 2001 60 1 164 173 11408611
   PubMed Web of Science ®Google Scholar
• Gilles HM Management of Severe Malaria: A Practical Handbook 2nd ed Geneva World Health Organization 2000
   Google Scholar
• Coatney GR Cooper WC Eddy NB Greengerg J Survey of antimalarial agents: chemotherapy of Plasmodium gallinaceum infections; toxicity; correlation of structure and action Public Health Monogr 1953 9 1 322 13037947
   PubMedGoogle Scholar
• De D Krogstad FM Cogswell FB Krogstad DJ Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro Am J Trop Med Hyg 1996 55 6 579 583 9025680
   PubMed Web of Science ®Google Scholar
• Scheibel LW Adler A Trager W Tetraethylthiuram disulfide (Antabuse) inhibits the human malaria parasite Plasmodium falciparum Proc Nat Acad Sci U S A 1979 76 10 5303 5307
   Web of Science ®Google Scholar
• Scheibel LW Adler A Antimalarial activity of selected aromatic chelators Mol Pharmacol 1980 18 2 320 325 6775184
   PubMed Web of Science ®Google Scholar
• Scheibel LW Adler A Antimalarial activity of selected aromatic chelators. II. Substituted quinolines and quinoline-N-oxides Mol Pharmacol 1981 20 1 218 223 6793844
   PubMed Web of Science ®Google Scholar
• Owens RG Studies on the nature of fungicidal action. I. Inhibition of sulfhydryl-, amino-, iron-, and copper-dependent enzymes in vitro by fungicides and related compounds Contr Boyce Thompson Inst 1953 17 3 221 242
   Google Scholar
• Denton H Roberts CW Alexander J Thong KW Coombs GH Enzymes of energy metabolism in the bradyzoites and tachyzoites of Toxoplasma gondii FEMS Microbiol Lett 1996 137 1 103 108 8935663
   PubMed Web of Science ®Google Scholar
• McCarthy SM Davis CD Prooxidant diet provides protection during murine infection with Toxoplasma gondii J Parasitol 2003 89 5 886 894 14627133
   PubMed Web of Science ®Google Scholar
• Pino P Foth BJ Kwok LY Dual targeting of antioxidant and metabolic enzymes to the mitochondrion and the apicoplast of Toxoplasma gondii PLoS Pathog 2007 3 8 e115 17784785
   PubMed Web of Science ®Google Scholar
• Martirosyan A Leonard S Shi X Griffith B Gannett P Strobl J Actions of a histone deacetylase inhibitor NSC3852 (5-nitroso-8-quinolinol) link reactive oxygen species to cell differentiation and apoptosis in MCF-7 human mammary tumor cells J Pharmacol Exp Ther 2006 317 2 546 552 16497787
   PubMed Web of Science ®Google Scholar
• Henry TR Wallace KB Differential mechanisms of cell killing by redox cycling and arylating quinones Arch Toxicol 1996 70 8 482 489 8783811
   PubMed Web of Science ®Google Scholar
• Reis DC Pinto MC Souza-Fagundes EM Investigation on the pharmacological profile of antimony(III) complexes with hydroxyquinoline derivatives: anti-trypanosomal activity and cytotoxicity against human leukemia cell lines Biometals 2011 24 4 595 601 21221718
   PubMed Web of Science ®Google Scholar
• Halliwell B Gutteridge JM Oxygen toxicity, oxygen radicals, transition metals and disease Biochem J 1984 219 1 1 14 6326753
   PubMed Web of Science ®Google Scholar
• Valko M Morris H Cronin MT Metals, toxicity and oxidative stress Curr Med Chem 2005 12 10 1161 1208 15892631
   PubMed Web of Science ®Google Scholar
• Mau JL Lin HC Song SF Antioxidant properties of several specialty mushrooms Food Res Int 2002 35 6 519 526
   Web of Science ®Google Scholar
• Roby MHH Sarhan MA Selim KAH Khalel KI Evaluation of antioxidant activity, total phenols and phenolic compounds in thyme (Thymus vulgaris L.), sage (Salvia officinalis L.), and marjoram (Origanum majorana L.) extracts Ind Crops Prod 2013 43 827 831
   Web of Science ®Google Scholar
• Ma L Liu Z Zhou B Yang L Liu Z Inhibition of free radical induced oxidative hemolysis of red blood cells by green tea polyphenols Chin Sci Bull 2000 45 22 2052 2056
   Google Scholar
• Prachayasittikul V Prachayasittikul S Ruchirawat S High therapeutic potential of Spilanthes acmella: A review EXCLI J 2013 12 291 312
   PubMed Web of Science ®Google Scholar
• Burton GW Ingold KU Vitamin E: application of the principles of physical organic chemistry to the exploration of its structure and function Acc Chem Res 1986 19 7 194 201
   Web of Science ®Google Scholar
• Spiteller G Linoleic acid peroxidation – the dominant lipid peroxidation process in low density lipoprotein – and its relationship to chronic diseases Chem Phys Lipids 1998 95 2 105 162 9853364
   PubMed Web of Science ®Google Scholar
• Mechlovich D Amit T Mandel SA The novel multifunctional, iron-chelating drugs M30 and HLA20 protect pancreatic beta-cell lines from oxidative stress damage J Pharmacol Exp Ther 2010 333 3 874 882 20237072
   PubMed Web of Science ®Google Scholar
• Fernández-Bachiller MI Pérez C González-Munoz GC Novel tacrine – 8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer’s disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties J Med Chem 2010 53 13 4927 4937 20545360
   PubMed Web of Science ®Google Scholar
• Çolak AT Çolak F Yeşilel OZ Büyükgüngör O Synthesis, spectroscopic, thermal, voltammetric studies and biological activity of crystalline complexes of pyridine-2,6-dicarboxylic acid and 8-hydroxyquinoline J Mol Struct 2009 936 1–3 67 74
   Web of Science ®Google Scholar
• Czapski G Goldstein S Requirements for SOD mimics operating in vitro to work also in vivo Free Radic Res Commun 1991 12–13 Pt 1 167 171 22422014
   PubMedGoogle Scholar
• Wang Y Yang ZY Wang BD Synthesis, characterization and anti-oxidative activity of cobalt(II), nickel(II) and iron(II) Schiff base complexes Transit Metal Chem 2005 30 879 883
   Web of Science ®Google Scholar
• Suksrichavalit T Prachayasittikul S Nantasenamat C Isarankura-Na-Ayudhya C Prachayasittikul V Copper complexes of pyridine derivatives with superoxide scavenging and antimicrobial activities Eur J Med Chem 2009 44 8 3259 3265 19375194
   PubMed Web of Science ®Google Scholar
• Suksrichavalit T Prachayasittikul S Piacham T Isarankura-Na-Ayudhya C Nantasenamat C Prachayasittikul V Copper complexes of nicotinic-aromatic carboxylic acids as superoxide dismutase mimetics Molecules 2008 13 12 3040 3056 19078847
   PubMed Web of Science ®Google Scholar
• MacMicking J Xie QW Nathan C Nitric oxide and macrophage function Annu Rev Immunol 1997 15 323 350 9143691
   PubMed Web of Science ®Google Scholar
• Kim YH Woo KJ Lim JH 8-Hydroxyquinoline inhibits iNOS expression and nitric oxide production by down-regulating LPS-induced activity of NF-kappaB and C/EBPbeta in Raw 264.7 cells Biochem Biophys Res Commun 2005 329 2 591 597 15737626
   PubMed Web of Science ®Google Scholar
• Alderton WK Cooper CE Knowles RG Nitric oxide synthases: structure, function and inhibition Biochem J 2001 357 Pt 3 593 615 11463332
   PubMed Web of Science ®Google Scholar
• Rao KM Molecular mechanisms regulating iNOS expression in various cell types J Toxicol Environ Health B Crit Rev 2000 3 1 27 58 10711324
   PubMed Web of Science ®Google Scholar
• Lee AK Sung SH Kim YC Kim SG Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-alpha and COX-2 expression by sauchinone effects on I-kappaBalpha phosphorylation, C/EBP and AP-1 activation Br J Pharmacol 2003 139 1 11 20 12746218
   PubMed Web of Science ®Google Scholar
• Xie QW Kashiwabara Y Nathan C Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase J Biol Chem 1994 269 7 4705 4708 7508926
   PubMed Web of Science ®Google Scholar
• Hu H Shih R Rothenberg S Schwartz BS The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues Environ Health Perspect 2007 115 3 455 462 17431499
   PubMed Web of Science ®Google Scholar
• Kosnett MJ Becker CE Osterloh JD Kelly TJ Pasta DJ Factors influencing bone lead concentration in a suburban community assessed by noninvasive K x-ray fluorescence JAMA 1994 271 3 197 203 8277545
   PubMed Web of Science ®Google Scholar
• Menke A Muntner P Batuman V Silbergeld EK Guallar E Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults Circulation 2006 114 13 1388 1394 16982939
   PubMed Web of Science ®Google Scholar
• Shih RA Hu H Weisskopf MG Schwartz BS Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead Environ Health Perspect 2007 115 3 483 492 17431502
   PubMed Web of Science ®Google Scholar
• Weisskopf MG Proctor SP Wright RO Cumulative lead exposure and cognitive performance among elderly men Epidemiology 2007 18 1 59 66 17130688
   PubMed Web of Science ®Google Scholar
• Bergdahl IA Grubb A Schütz A Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes Pharmacol Toxicol 1997 81 4 153 158 9353844
   PubMedGoogle Scholar
• Paglia DE Valentine WN Dahlgren JG Effects of low-level lead exposure on pyrimidine 5′-nucleotidase and other erythrocyte enzymes. Possible role of pyrimidine 5′-nucleotidase in the pathogenesis of lead-induced anemia J Clin Invest 1975 56 5 1164 1169 1184742
   PubMed Web of Science ®Google Scholar
• Boas FE Forman L Beutler E Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia Proc Nat Acad Sci U S A 1998 95 6 3077 3081
   Web of Science ®Google Scholar
• Chiu D Lubin B Roelofsen B van Deenen LL Sickled erythrocytes accelerate clotting in vitro: an effect of abnormal membrane lipid asymmetry Blood 1981 58 2 398 401 7248527
   PubMed Web of Science ®Google Scholar
• Shin JH Lim KM Noh JY Lead-induced procoagulant activation of erythrocytes through phosphatidylserine exposure may lead to thrombotic diseases Chem Res Toxicol 2007 20 1 38 43 17226925
   PubMed Web of Science ®Google Scholar
• Rogan WJ Dietrich KN Ware JH Treatment of Lead-Exposed Children Trial Group The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead N Eng J Med 2001 344 19 1421 1426
   PubMed Web of Science ®Google Scholar
• Hamidinia SA Erdahl WL Chapman CJ Steinbaugh GE Taylor RW Pfeiffer DR Monensin improves the effectiveness of meso-dimercaptosuccinate when used to treat lead intoxication in rats Environ Health Perspect 2006 114 4 484 493 16581534
   PubMed Web of Science ®Google Scholar
• Sakai T Yanagihara S Kunugi Y Ushio K Mechanisms of ALA-D inhibition by lead and of its restoration by zinc and dithiothreitol Br J Ind Med 1983 40 1 61 66 6824601
   PubMedGoogle Scholar
• Meredith PA Moore MR Goldberg A Effects of aluminium, lead and zinc on delta-aminolevulinic acid dehydratase Enzyme 1977 22 1 22 27 837892
   PubMedGoogle Scholar
• Jin S Cheng Y Reid S Li M Wang B Carbohydrate recognition by boronolectins, small molecules, and lectins Med Res Rev 2010 30 2 171 257 19291708
   PubMed Web of Science ®Google Scholar
• Phillips MD Fyles TM Barwell NP James TD Carbohydrate sensing using a fluorescent molecular tweezer Chem Commun (Camb) 2009 43 6557 6559 19865648
   PubMed Web of Science ®Google Scholar
• Ardá A Venturi C Nativi C A chiral pyrrolic tripodal receptor enantioselectively recognizes beta-mannose and beta-mannosides Chemistry 2010 16 2 414 418 19998432
   PubMed Web of Science ®Google Scholar
• Davis AP Synthetic lectins Org Biomol Chem 2009 7 18 3629 3638 19707662
   PubMed Web of Science ®Google Scholar
• Mazik M Geffert C 8-Hydroxyquinoline as a building block for artificial receptors: binding preferences in the recognition of glycopyranosides Org Biomol Chem 2011 9 7 2319 2326 21321767
   PubMed Web of Science ®Google Scholar
• Melnik B John SM Schmitz G Over-stimulation of insulin/IGF-1 signaling by western diet may promote diseases of civilization: lessons learnt from Laron syndrome Nutr Metab (Lond) 2011 8 1 41 21699736
   PubMed Web of Science ®Google Scholar
• Cheng Z White MF Targeting forkhead box O1 from the concept to metabolic diseases: lessons from mouse models Antioxid Redox Signal 2011 14 4 649 661 20615072
   PubMed Web of Science ®Google Scholar
• Salih DA Brunet A FoxO transcription factors in the maintenance of cellular homeostasis during aging Curr Opin Cell Biol 2008 20 2 126 136 18394876
   PubMed Web of Science ®Google Scholar
• Buteau J Accili D Regulation of pancreatic beta-cell function by the forkhead protein FoxO1 Diabetes Obes Metab 2007 9 Suppl 2 140 146 17919188
   PubMed Web of Science ®Google Scholar
• Rains JL Jain SK Oxidative stress, insulin signaling, and diabetes Free Radic Biol Med 2011 50 5 567 575 21163346
   PubMed Web of Science ®Google Scholar
• Cameron AR Anil S Sutherland E Harthill J Rena G Zinc-dependent effects of small molecules on the insulin-sensitive transcription factor FOXO1a and gluconeogenic genes Metallomics 2010 2 3 195 203 21069157
   PubMed Web of Science ®Google Scholar
• Cameron AR Wallace K Logie L The anti-neurodegenerative agent clioquinol regulates the transcription factor FOXO1a Biochem J 2012 443 1 57 64 22248233
   PubMed Web of Science ®Google Scholar
• Kitamura T Nakae J Kitamura Y The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth J Clin Invest 2002 110 12 1839 1847 12488434
   PubMed Web of Science ®Google Scholar